Two studies extensively analyze blood vessels in the human brain on a single-cell level and show that changes in the molecular makeup of these vessels are linked to dementia.
Read the NIA Director's statement on CMS Medicare coverage policy for approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s